These studies pursuant to animal studies could possibly determine the use of NK1R antagonism as a novel therapeutic strategy for the prevention of cisplatin-induced neurotoxicity and enhancement of the efficacy of chemotherapy in cancer. The gene discussed is TACR1; the disease is cancer.